I actually said I’d try. I refuse to post just to post.

We sent out a Trading Alert on Eden Energy on Tuesday. Have a read. While all oil exploration concerns are risky by nature, the potential for Eden at it’s Noah Project is enormous. Here’s the chart:

If it plays out, it could be a multi-billion barrel field. Do the math. That’s serious oil and serious revenue/profits. Keep an eye on this one. Drilling program begins in the fall and should see results within several months. The share price is pretty much irrelevant at this point given the potential. It should mainly appeal to oil and gas investors who like the action when there is the potential for an elephant or a herd of elephants to arrive from this kind of exploration.

Kind of quiet this week, but boat maker Xtreme announced a distributor in Turkey for its security/patrol boats which are way cool and extremely functional. The share price at 27-ish cents can’t seem to get going, but even though the company may seem mundane, the announcements and sales recently make me think this is a sleeper.

Force Protection continues to confound. No news and the shares bouncedd off support at $1.50 to cruise up to $1.90 for a cool 2-3 day trade. Now at $1.75, it appears relatively stable. Traders enjoy. Keep an eye on that $1.50 level. Til more news comes out, it’s a trader.

Micromuse popped up to $5 on decent earnings numbers. Still think this is a decent long-term story.

Informatica popped up to $8 on nothing of note and I still contend that it is both a good company and may eventually be of interest to one of the big boys. Buy it for the business, not for a takeout.

What else… Bottomline reported good earnings and other corporate stuff which popped the stock $1.25, Thursday. Read the details here. We profiled the company in November in the SmallCap Digest at just under $11. While it hasn’t been a ripper–yet–prospects look solid for continued growth. Given how ugly the market’s been of late, idling to slightly up is a win. It popped to $17 in December for no apparent reason, so likely a goodd trader. A bust past $13 would be nifty for a new upleg.

That’s it for now. Comments welcome, always.

Trade safely.

Earth Day: Make an environmentalist buy you lunch. (don’t email me, I’m kidding) I’m planting a tree later today.

Seems the nifty action of the last couple of days is pretty much exclusive to the big stocks, with the smallcaps lagging. If, as we suspect the rally gets renewed legs, there are some decent prices out there for long-term investors and traders alike.

We’ll go down the list with alphabetically as that’s the way I have them listed.

Oh, by the way, we’ll have another really unique new newsletter idea in the oil and gas arena for Monday after the close–watch your inbox.

Speaking of Oil and Gas, one that’s been a disappointment recently, Assure Energy appears to be gathering some steam as the company does some reorganizing and reports drilling results. Might be worth averaging down to lower a higher cost price. We still like the shares, but the business plan is taking longer than expected to execute. Definitely in the right sector, and we look forward to more machinations to bring it forward.

Biophan continues to move ahead and over the last week has been a trader’s dream. We still hold to our view that this stock makes sense for the longterm. Trade it if you like, but keep a few shares in the lockup portion of your portfolio. The Company is very good at releasing substantive news on a relatively frequent basis.

Biocurex seems stuck in the $1.25-$1.50 range. I think you have to own it for those who share the vision, are patient to wait for the Abbott deal to kick in as well as potential new deals and other R&D developments as the company moves forward. This one moves fast when the market comes to buy it so again, a core position in the spec end of the portfolio is suggested. Price seems secondary at the moment given the news recently and, we believe, news to come.

Force Protection has been a topic here recently and I have nothing further to add. The company needs to get out there and promote itself more. Armor Holdings, which up-armors Hummers was on CNBC this am with a good piece. FRPT should do the same, given that in my opinion, they have a better product. Support at $1.50. I’ve got nothing else.

Isonics has been disappointing lately, but I suspect that will change soon. I’m looking into this one, but considering the shares have fallen in half and nothing bad has happened, I put it down to a lack of news and crappy markets. As well, the company has addressed a few challenges recently–here– and hopefully will get it together soon.

MIV Therapeutics has been a subject a couple of times in the recent newsletters. Not much more to say other than the technology is amazing, proprietary and if you had cardiac problems, you’d want these products onboard. So will millions of others, we suspect. Interesting company with real-world, practical and ultimately very profitable biotech. You should have some.

Spectrum has also been done here frequently. Shares have been weak likely on shorting and ’sell on news’ regarding the Horne acquisition which appears to be very much on track. Company announced a stock buyback Friday morning which is obviously a positive. Spectrum isn’t for the faint of heart, but for those who can stand the heat, getting in on the right side of a move can be a good trade. I’m think $1.50 looks a decent level for accumulation, but keep an eye on it. Longterm, I’m not concerned, short term it will continue to roil around.

Finally, little boater Xtreme has sold a dozen boats to one dealer in the last month which is likely around a $million in sales for the month give or take. It just signed another bigtime dealer in Missouri and I suspect that investors haven’t yet figured this one out.
Simple: if Xtreme sells a lot of boats, it will make lots of money and the share price will rise. We think that it will sell a lot of Challenger boats as well as patrol/security boats in its Homeland Security division. Still formative, but things seem to be moving fast.

We had a couple of others additions to the list including Spescom Software and Stream Communications and it’s a little early to update other than to say they are both unique and appear to have oodles of potential.

Comments welcome. Send ‘em in.

Trade Safely.

For reasons that I can’t discern, Spectrum got pounded this am and hit $1.36. Currently $1.55 the shares appear to have bounced back on over 1 million shares. I can’t see or find any reason for this–not to say that there isn’t one, but for those with strong constitutions, might be worth a punt. You’re on your own, unless someone has any news or information, including moi. If I hear anything, I’ll add to this post.

This puppy’s never dull…

Looks like a decent halt to last week’s slide. Keep frosty over the next couple of days as we see if this level holds. It shouldn’t take long to decide which way it wants to go.

Force Protection seems to have halted its decline below $1.50, but you’d be right to be vigilant. Would like to see it consolidate higher, frankly, but the bounce off of $1.50 looked, well, ok.

Seems Sec of State Donald Rumsfeld got a look at a Buffalo in Iraq and the soldiers extolled the virtues of same to DR. Now, if he’d just go back and make the call to the quartermaster, we could get this puppy to sit up and beg.

Seriously though, this is a good exposure for the company especially if DR makes mention of the vehicles in a speech, press conference etc. Still doesn’t take the place of fresh orders, but it’ll do for now. One day at a time.

Here’s where we are, technically. If the shares can close above the 3×3 moving average, then close below, then close above again and hold, that would likely signal a reversal in the shares. It needs to do this soon, otherwise the 3×3 line looks a good reference point to lighten up or sell outright. A sharp eye is called for at this juncture.

Trade safely.

Well, that was a nasty day, but I think constructive, come Monday or thereabouts. Dow was off 190-ish, NAZ dove 38 and change.

Here’s the chart:

Included in the chart is the DiNapoli Oscillator which is an excellent indicator of overbought/oversold levels. As of today’s activity, it has declined to the level that heralded the very beginning of the rally last August. As well, and this is way cool, we’ve simultaneously completed the .618 percent retracement of that previous Aug-Dec rally. So technically, this week’s ugly action looks constructive for a decent rally from or near these levels. No guarantees, but given the picture that logic looks a reasonable technical assessment. Monday will be interesting. Some decent prices out there as a result of this carnage. Not a lot of point is talking specific stocks, as just about everything got pounded.

I’m up for some comments and discussion over the weekend if y’all have any thoughts. I’ve been up since 4 am this am anyway, so might as well stick around.

Trade safely.

Thought it would be useful to show y’all a picture of a fairly vicious whipsaw. Our example is Spectrum, which is never dull, always volatile and can move either way like greased lightning. Here’s the chart:

The shares closed, Tuesday, just above $2. One of those rogue sell orders seems to have appeared and roiled the shares down to $1.78 just after the opening, Wednesday. After the willy-nilly sell at any cost trader finished, the shares quickly bounced and closed at $2.12. For those who had stop losses, they may well have been triggered and if a position wasn’t re-established, the resultant whipsaw may have left some investors position-less. Welcome to the smallcap market.

The good news is that with the quick pullback, the shares retraced that all important .618 percent of the previous run, likely washing out the weak knees and setting the shares up for what is often, after a situation such as this, a decent bullish sign. We are waiting for news from SPSC and the decline was likely the result of a combination of factors. While the decline was fairly nasty, it likely was a good ‘cleansing’ of the shares.

But this is Spectrum, one of the best personifications of volatility in the Smallcap market. Being on one’s toes is the least attention the shares should be paid. And once all the recent corporate activity gels, my feeling is that the future is extremely compelling.

Don’t blink and trade safely.

Yeah, busy spiking a couple of stories, looking at new ideas–hopefully a neat software company next week–and coping with offline life in general. But some good things happening, so fasten your seatbelt.

MIV Therapeutics got the newsletter treatment yesterday detailing a couple of extremely interesting patents filed to enhance the efficacy of cardiac stents and other critical implanted devices. Have a read as I believe this company at 50-odd cents represents a decent shot at the big-time.

Busy Biocurex has been, what a surprise, volatile and seems to be content to stay above the $1.20 support area. I personally think it should be higher, and we saw a flurry of $1.50 trade earlier in the week. The lackluster trade is for all the previous reasons noted–Pink sheets, some shorting etc. Longterm, these prices–or at least around this level–will, in my opinion, look cheap. And once the company gets off the Pinks…

Interesting post on Raging Bull by a fellow–Bruce– who comments here frequently. His hypothesis is long and exhaustive and makes for an interesting read on the cancer diagnostic market and BOCX’s potential– as he sees it– within that sector. Have a peak for some good digging into the subject and the stock.

Also, Biocurex will be featured on various channels in the US over the weekend in an interview piece that was done last year. Don’t think there will be any news on the Abbott deal, but will likely bring in some new eyeballs which is always good. I’m attempting to get a link to the schedule and will post when I do. It’s on at various times all over the place, some don’t want to waste the bandwidth here.

Will report on BOCX as news develops. Still think the shares don’t reflect the potential.

Ah, Force Protection. I’ve noted on several occasions my annoyance that more news hasn’t been forthcoming and the share price activity has been weak to say the least. Here’s a chart:

Barring any news, the shares will likely remain stuck in a range from $1.60-$1.80. Pops could take it to $1.90-$2.09, but that’s still well under the post reverse split range. More importantly, while there is significant support at $1.55 a breach of that level wouldn’t be constructive. For those who want to hang on, a stop at or below $1.55 is likely prudent or you could sell some and look elsewhere. As I’ve also said, the company has good prospects, products in a sector that desperately needs them. The lack of recent progress has simply added to the decline. As I said, annoying.

Data integrator Micromuse had a nice trade post our March 24 post below. The shares popped up over $5 Thursday and the company announced it was spending some cash ($33 million of its $124 million) to buy private Quallaby Corp of Lowell, Mass. The details are here and the deal, to close in six weeks, is apparently revenue neutral for 2005 and accretive for 2006. The two companies have worked closely on client solutions in the past so it looks like this one could be good and easily integrated. Shares look good as long as they stay above $4.15 which is where the stop should be placed.

A point about stops: to protect capital, stops make eminent sense. However, especially in the smallcap market, the swings and roundabouts can be vicious and rapid. A selling climax or buying binge can trigger a stop and then bounce back, leaving you out of the stock as it resumes its appreciation or decline, depending if you want to be long or short. This is of course, the infamous ‘whipsaw’ and happens frequently in the small cap arena. Be aware of this and act accordingly.

Perhaps stops should be staggered to protect against whipsaws. Just another tip that might help so you don’t experience stock separation anxiety if you’re the victim of a whipsaw. Just a thought.

Trade Safely.

As happens in these occasions, our new idea, at the 11th hour hadn’t answered all of our queries. So we spiked it. Might return, might not. We are always looking at lots of other stuff. You can go back to yellow alert… We’re not in the business of bringing you anything but the best.

Trade Safely…

Monday after the close, we’ll be publishing a piece–if all things come to pass–about a nifty company that has tentacles in the socially responsible arena. It possesses a technology that economically produces a product that could have global impact, especially in developing countries. The business model is simple and we believe will have the potential to grow into a major player in its sector. Interested? Make sure you sign up in the top left corner for the newsletter if you haven’t already

We’re back on Biophan, one of our many faves which we’re covered for the last 18 months. Even though the shares have moved higher in the last few months, we feel that long-term investors would do well to get involved. The growth of its intellectually property portfolio is impressive and with the specter of further joint ventures and eventual licensing deals, as I said, this ain’t your previous Biophan. Have a read.

Finally, Biocurex had a good day Friday, after a volatile week. We have said just about all we can say at this point and the shares appear to have bottomed at $1.05 in a selling climax, Thursday, and closed on the high at $1.50, Friday. The salient number for support is $1.20 and as long as the shares close above that level, the uptrend appears intact. Technically, a breakdown below $1.20 would look like the next stop would be the mid-80 cent level.

As I have said, the shares will likely continue to be volatile, but the action this week appears to have blown out some weak holders and now the shares appear to be going into stronger hands. I firmly believe that it isn’t all about price at this point it’s about potential and more news/deals to come, although the Abbott deal is a phenomenal start. Do the long-term math. It’s pretty exciting. We’ll see. Trade strategically.

And safely. I’ll comment as the week goes on.